Troubleshooting the rabbit ferric chloride-induced arterial model of thrombosis to assess in vivo efficacy of antithrombotic drugs

被引:10
|
作者
Couture, L. [1 ]
Richer, L. P. [1 ]
Mercier, M. [1 ]
Helie, C. [1 ]
Lehoux, D. [2 ]
Hossain, S. M. [1 ]
机构
[1] Natl Res Council Canada, Montreal, PQ H4P 2R2, Canada
[2] Medicines Co, St Laurent, PQ H4S 2A1, Canada
关键词
Antithrombotic drug; Blood flow; Ferric chloride; Methods; Rabbit; Time to occlusion; FACTOR-XA INHIBITOR; OPTICAL COHERENCE TOMOGRAPHY; CAROTID-ARTERY; RAT MODEL; VITRO; ANTICOAGULANT; DX-9065A;
D O I
10.1016/j.vascn.2012.11.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: The FeCl3-induced arterial model of thrombosis is one of the most widely used animal models to assess arterial efficacy of new antithrombotic drug candidates. This model is well-established in rodents but in a less extent in the rabbit. In this work, we present a methodology for a rabbit FeCl3-induced arterial model of thrombosis derived from our troubleshooting which allows the generation of reliable efficacy data for new antithrombotic drug candidates. Methods: Rabbits were administered with heparin 4.5 U/kg/min, argatroban 10 mu g/kg/min or saline by intravenous infusion. The blood flow was monitored using a Doppler flow probe. The time from the application of FeCl3 to the recorded zero blood flow was defined as the time to occlusion, with a maximum recording time of 60 min post-FeCl3 application. After 30 min of infusion, thrombosis was induced by wrapping a FeCl3-saturated filter paper around the carotid artery caudal to the flow probe. Animals were subject to exclusion criteria based on the visual aspect of the artery FeCl3-induced injury and based on changes in blood flow upon FeCl3 application. Results: Following the application of FeCl3, a mean time to occlusion for saline, heparin and argatroban of 24.3+/-1.8, 52.5+/-4.8 and 53.5+/-4.5 min was obtained, respectively. Mean time to occlusion for heparin and argatroban administered groups was significantly different when compared to the saline-treated group (p<0.05). These results for the test compounds represent approximately 80% of the maximum possible prolongation. Discussion: The rabbit FeCl3-induced arterial model of thrombosis presented in this paper derived from our troubleshooting is sensitive and reproducible for the generation of accurate and reliable efficacy data in the assessment of newantithrombotic agents in preclinical drug development. Crown Copyright (C) 2012 Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:91 / 97
页数:7
相关论文
共 50 条
  • [41] A recombinant protein and a chemically synthesized peptide containing the active peptides of the platelet collagen receptors inhibit ferric chloride-induced thrombosis in a rat model
    Du, Haiming
    Zawaski, Janice A.
    Gaber, M. Waleed
    Chiang, Thomas M.
    THROMBOSIS RESEARCH, 2007, 121 (03) : 419 - 426
  • [42] Thrombolytic Effects of Philippine Pit Viper (Trimeresurus flavomaculatus) Venom in Human Blood In Vitro and Ferric Chloride-Induced Cardiac Thrombosis on Swiss Webster Mice In Vivo
    Alcachupas, Aljeirou
    Bellosillo, Krisverlyn
    Catolico, Wynlee Rhm
    Davis, Mark Cullen
    Diaz, Alyssa
    Doyongan, Yvette Karla
    Eduarte, Reczy
    Gersava, Emerald
    Intrepido, Mary Bernadette
    Lavalle, Candra Carmelli
    Millan, Jeffrey
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
  • [43] Local overexpression of thrombomodulin for in vivo prevention of arterial thrombosis in a rabbit model.
    Kuo, MD
    Waugh, JM
    Li, J
    Yuksel, E
    Kattash, M
    Saxena, R
    Thung, SN
    Shenaq, SM
    Woo, SLC
    FASEB JOURNAL, 1998, 12 (05): : A954 - A954
  • [44] Antithrombotic effects of recombinant human, active site blocked factor VIIa in a rabbit model of arterial thrombosis
    Golino, P
    Ragni, M
    Cirillo, P
    D'andrea, D
    Scognamiglio, A
    Ravera, A
    Buono, C
    Ezban, M
    Corcione, N
    Vigorito, F
    Chiariello, M
    THROMBOSIS AND HAEMOSTASIS, 1999, : 582 - 582
  • [45] Animal model of arterial and venous thrombosis in dogs: Assessment of the efficacy of various antithrombotic strategies.
    Mu, DX
    Mousa, SA
    FASEB JOURNAL, 1996, 10 (03): : 2506 - 2506
  • [46] Motor deficit in the mouse ferric chloride-induced distal middle cerebral artery occlusion model of stroke
    Syeara, Nausheen
    Alamri, Faisal F.
    Jayaraman, Srinidhi
    Lee, Peia
    Karamyan, Serob T.
    Arumugam, Thiruma, V
    Karamyan, Vardan T.
    BEHAVIOURAL BRAIN RESEARCH, 2020, 380
  • [47] Deficiency in thrombin-activatable fibrinolysis inhibitor (TAFI) protected mice from ferric chloride-induced vena cava thrombosis
    Xinkang Wang
    Patricia L. Smith
    Mei-Yin Hsu
    Joseph A. Tamasi
    Eileen Bird
    William A. Schumacher
    Journal of Thrombosis and Thrombolysis, 2007, 23 : 41 - 49
  • [48] Deficiency in thrombin-activatable fibrinolysis inhibitor (TAFI) protected mice from ferric chloride-induced vena cava thrombosis
    Wang, Xinkang
    Smith, Patricia L.
    Hsu, Mei-Yin
    Tamasi, Joseph A.
    Bird, Eileen
    Schumacher, William A.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2007, 23 (01) : 41 - 49
  • [49] CD39 Expression on Circulating Blood Components Prolongs the Time to Ferric Chloride-Induced Carotid Artery Thrombosis in Mice
    Reynolds, Adam
    Huttinger, Zachary M.
    Aurand, William L.
    Huttinger, Ryan M.
    Stanfill, Katerine
    Wheeler, Debra G.
    Novitskaya, Tatiana
    Robson, Simon C.
    Dwyer, Karen M.
    Dwyer, Peter J.
    Gumina, Richard J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34
  • [50] Intravenous apyrase administration reduces arterial thrombosis in a rabbit model of endothelial denudation in vivo
    Costa, AF
    Gamermann, PW
    Picon, PX
    Mosmann, MP
    Kettlun, AM
    Valenzuela, MA
    Sarkis, JJF
    Battastini, AMO
    Picon, PD
    BLOOD COAGULATION & FIBRINOLYSIS, 2004, 15 (07) : 545 - 551